Financial challenges are the No. 1 barrier patients cite to getting a blood stem cell transplant. Each day, NMDP receives 15 grant requests from patients needing help with transplant-related expenses ...

The bond between siblings is strong from the start, but when one saves the other’s life, that bond becomes unbreakable.

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

A Los Angeles boy is being credited with saving the life of his father by donating stem cells to help treat his dad’s leukemia. Just nine years old at the time, Stephen Mondek is the youngest person ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...

Please provide your email address to receive an email when new articles are posted on . Many years of research led to the approval of a breakthrough cell therapy for corneal endothelial dysfunction in ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

Chronic graft-versus-host disease (cGvHD) is a major complication following allogeneic hematopoietic cell transplantation (allo-HCT). More than half of transplant patients are diagnosed with cGvHD.